RxDoctor Payments Data

Robert Huang, MD

Otolaryngology · Iselin, NJNPI 1740200096

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.

$3,765in general payments, 2019–2025

Across 182 payments — averaging $20.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$732
  • Sanofi$631
  • Optinose US, Inc.$511
  • Regeneron Healthcare Solutions, Inc.$465
  • GSK$430
  • CSL Behring$179
  • plus $818 from 20 others

What the payments were for

  • Food & beverage$3,71299%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,765 in reported general payments places this provider in the 85th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$278,558
Medicare patients
502
Services billed
1,806

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate428$6,574
RestasisCyclosporine11$5,353
Fluocinolone Acetonide Oil45$2,471
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav159$1,327
Cefdinir50$1,013
Pilocarpine Hcl13$805
Meclizine Hcl51$563
Ofloxacin19$442
Ipratropium Bromide22$437
Tobramycin-DexamethasoneTobramycin/Dexamethasone13$312
Omeprazole61$295
Montelukast Sodium27$291
Clindamycin Hcl22$232
Azelastine Hcl12$217
Levocetirizine Dihydrochloride20$161

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Iselin

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →